ใ‚ใ‹ใ‚‹ๅŒปๅญฆ่ซ–ๆ–‡
  • ใƒ›ใƒผใƒ 
ๆ–ฐ็€่ซ–ๆ–‡ ใ‚ตใ‚คใƒˆใƒžใƒƒใƒ—
2025.09.04 ๅ…็–ซ็™‚ๆณ•

่„ณ่…ซ็˜ใฎๅ…็–ซ็›ฃ่ฆ–ใจใŒใ‚“ๅ…็–ซ็™‚ๆณ•ใ‚’ๅ‘ไธŠใ•ใ›ใ‚‹ใŸใ‚ใฎ่…ซ็˜ๅ†…ๅฃŠๆญป่„‚่ณชๆ”พๅ‡บใฎๆจ™็š„ๅŒ–

Targeting necrotic lipid release in tumors enhances immunosurveillance and cancer immunotherapy of glioblastoma.

TOP ๏ผž ๅ…็–ซ็™‚ๆณ• ๏ผž ่จ˜ไบ‹่ฉณ็ดฐ

๐Ÿง  ่„ณ่…ซ็˜ใฎๅ…็–ซ็›ฃ่ฆ–ใจใŒใ‚“ๅ…็–ซ็™‚ๆณ•ใ‚’ๅ‘ไธŠใ•ใ›ใ‚‹ใŸใ‚ใฎ่…ซ็˜ๅ†…ๅฃŠๆญป่„‚่ณชๆ”พๅ‡บใฎๆจ™็š„ๅŒ–

่„ณ่…ซ็˜ใ€็‰นใซ็ฅž็ตŒ่† ่…ซ๏ผˆGBM๏ผ‰ใฏใ€ๅ…็–ซ็ณปใ‹ใ‚‰ใฎๆ”ปๆ’ƒใ‚’ๅ›ž้ฟใ™ใ‚‹ใŸใ‚ใซ้€ฒๅŒ–ใ—ใ€ๅ…็–ซๆŠ‘ๅˆถ็š„ใชๅพฎๅฐ็’ฐๅขƒใ‚’็ขบ็ซ‹ใ—ใพใ™ใ€‚ใ“ใ‚Œใซใ‚ˆใ‚Šใ€ใŒใ‚“ๅ…็–ซ็™‚ๆณ•ใฎๅŠนๆžœใŒๅˆถ้™ใ•ใ‚Œใ‚‹ใ“ใจใŒใ‚ใ‚Šใพใ™ใ€‚ๆœ€่ฟ‘ใฎ็ ”็ฉถใงใฏใ€่…ซ็˜ๅ†…ใฎๅฃŠๆญปใŒ่„‚่ณชใฎๆ”พๅ‡บใ‚’ๅผ•ใ่ตทใ“ใ—ใ€ใ“ใ‚ŒใŒๅ…็–ซ็›ฃ่ฆ–ใซใฉใฎใ‚ˆใ†ใซๅฝฑ้Ÿฟใ‚’ไธŽใˆใ‚‹ใ‹ใŒๆ˜Žใ‚‰ใ‹ใซใ•ใ‚Œใพใ—ใŸใ€‚ๆœฌ่จ˜ไบ‹ใงใฏใ€่…ซ็˜ๅ†…ๅฃŠๆญป่„‚่ณชๆ”พๅ‡บใฎๆจ™็š„ๅŒ–ใŒ่„ณ่…ซ็˜ใซใŠใ‘ใ‚‹ๅ…็–ซ็›ฃ่ฆ–ใจใŒใ‚“ๅ…็–ซ็™‚ๆณ•ใ‚’ใฉใฎใ‚ˆใ†ใซๅ‘ไธŠใ•ใ›ใ‚‹ใ‹ใซใคใ„ใฆ่ฉณใ—ใ่งฃ่ชฌใ—ใพใ™ใ€‚

๐Ÿ”ฌ ็ ”็ฉถๆฆ‚่ฆ

ใ“ใฎ็ ”็ฉถใฏใ€ใƒžใ‚ฆใ‚นใฎ่…ซ็˜ใƒขใƒ‡ใƒซใ‚’็”จใ„ใฆใ€ใŒใ‚“ใฎๅ…็–ซ้€ƒ้ฟใจใŒใ‚“ๅ…็–ซ็™‚ๆณ•ใฎใƒ†ใ‚นใƒˆใ‚’่กŒใ„ใพใ—ใŸใ€‚็‰นใซใ€้ž็™Œๆ€งใฎใƒžใ‚ฆใ‚น่ƒšๆ€งๅนน็ดฐ่ƒžใ‹ใ‚‰ๆดพ็”Ÿใ—ใŸ่…ซ็˜ใƒขใƒ‡ใƒซใ‚’้–‹็™บใ—ใ€CRISPRใ‚นใ‚ฏใƒชใƒผใƒ‹ใƒณใ‚ฐใ‚’้€šใ˜ใฆใŒใ‚“ใฎๅ…็–ซ็ทจ้›†ใซๅฝฑ้Ÿฟใ‚’ไธŽใˆใ‚‹้บไผๅญใ‚’็‰นๅฎšใ—ใพใ—ใŸใ€‚

๐Ÿงช ๆ–นๆณ•

็ ”็ฉถ่€…ใŸใกใฏใ€่…ซ็˜ๆŠ‘ๅˆถ้บไผๅญใฎๅ–ชๅคฑใŒ่…ซ็˜ๅ†…ใฎๅฃŠๆญปใ‚’ๅผ•ใ่ตทใ“ใ—ใ€APOE่„‚่ณช็ฒ’ๅญใŒ็ดฐ่ƒžๅค–ใซๆ”พๅ‡บใ•ใ‚Œใ‚‹ใ“ใจใ‚’็™บ่ฆ‹ใ—ใพใ—ใŸใ€‚ใ•ใ‚‰ใซใ€่…ซ็˜ๅ†…ใฎๅฃŠๆญปใ—ใŸ้ ˜ๅŸŸใซๅผ•ใๅฏ„ใ›ใ‚‰ใ‚ŒใŸT็ดฐ่ƒžใฏ่„‚่ณชใ‚’่“„็ฉใ—ใ€ๆฉŸ่ƒฝไธๅ…จใซ้™ฅใ‚Šใพใ—ใŸใ€‚ใ“ใ‚Œใ‚‰ใฎ็พ่ฑกใ‚’้˜ปๆญขใ™ใ‚‹ใ“ใจใงใ€ๅ…็–ซ็›ฃ่ฆ–ใŒๅ›žๅพฉใ™ใ‚‹ใ“ใจใŒ็คบใ•ใ‚Œใพใ—ใŸใ€‚

๐Ÿ“Š ไธปใช็ตๆžœ

็ตๆžœ ่ฉณ็ดฐ
่…ซ็˜ๆŠ‘ๅˆถ้บไผๅญใฎๅ–ชๅคฑ Trp53้บไผๅญใฎๅ–ชๅคฑใŒ่…ซ็˜ๅ†…ใฎๅฃŠๆญปใ‚’ๅข—ๅŠ ใ•ใ›ใ‚‹ใ€‚
APOE่„‚่ณช็ฒ’ๅญใฎๆ”พๅ‡บ ๅฃŠๆญปใ—ใŸ่…ซ็˜็ดฐ่ƒžใ‹ใ‚‰APOE่„‚่ณช็ฒ’ๅญใŒๆ”พๅ‡บใ•ใ‚Œใ€T็ดฐ่ƒžใŒๆฉŸ่ƒฝไธๅ…จใซใ€‚
ๅ…็–ซ็›ฃ่ฆ–ใฎๅ›žๅพฉ ่„‚่ณชใฎๅ–ใ‚Š่พผใฟใ‚’้˜ปๅฎณใ™ใ‚‹ใ“ใจใงT็ดฐ่ƒžใฎๆฉŸ่ƒฝใŒๅ›žๅพฉใ€‚
ใƒ’ใƒˆGBMใซใŠใ‘ใ‚‹็›ธไบ’ไฝœ็”จ TP53ๅค‰็•ฐใ‚’ๆŒใคใƒ’ใƒˆGBMใซใŠใ„ใฆใ‚‚ๅŒๆง˜ใฎ็พ่ฑกใŒ็ขบ่ชใ•ใ‚ŒใŸใ€‚
ๆฒป็™‚ๅŠนๆžœใฎๅ‘ไธŠ ๆŠ—APOEใŠใ‚ˆใณๆŠ—PDCD1ๆŠ—ไฝ“ใฎไฝต็”จใŒๆŠ—GBMๅ…็–ซใ‚’ๅผทๅŒ–ใ—ใ€็”Ÿๅญ˜ๆœŸ้–“ใ‚’ๅปถ้•ทใ€‚

๐Ÿ’ญ ่€ƒๅฏŸ

ใ“ใฎ็ ”็ฉถใฏใ€่…ซ็˜ๅ†…ใฎๅฃŠๆญปใŒๅ…็–ซ้€ƒ้ฟใซๅฏ„ไธŽใ™ใ‚‹ใƒกใ‚ซใƒ‹ใ‚บใƒ ใ‚’ๆ˜Žใ‚‰ใ‹ใซใ—ใ€็‰นใซAPOE่„‚่ณช็ฒ’ๅญใŒT็ดฐ่ƒžใฎๆฉŸ่ƒฝใซไธŽใˆใ‚‹ๅฝฑ้Ÿฟใ‚’็คบใ—ใฆใ„ใพใ™ใ€‚่…ซ็˜ๆŠ‘ๅˆถ้บไผๅญใฎๅ–ชๅคฑใŒๅฃŠๆญปใ‚’ๅผ•ใ่ตทใ“ใ—ใ€ใ“ใ‚ŒใŒๅ…็–ซ็ณปใฎๆฉŸ่ƒฝใ‚’ไฝŽไธ‹ใ•ใ›ใ‚‹ใ“ใจใŒ็ขบ่ชใ•ใ‚Œใพใ—ใŸใ€‚ไปŠๅพŒใฎใŒใ‚“ๅ…็–ซ็™‚ๆณ•ใงใฏใ€่„‚่ณชใฎๅ–ใ‚Š่พผใฟใ‚’ๆจ™็š„ใซใ™ใ‚‹ใ“ใจใงใ€ๅ…็–ซ็›ฃ่ฆ–ใ‚’ๅผทๅŒ–ใ™ใ‚‹ๆ–ฐใŸใชใ‚ขใƒ—ใƒญใƒผใƒใŒๆœŸๅพ…ใ•ใ‚Œใพใ™ใ€‚

๐Ÿ“ ๅฎŸ็”Ÿๆดปใ‚ขใƒ‰ใƒใ‚คใ‚น

  • ใŒใ‚“ๅ…็–ซ็™‚ๆณ•ใซ้–ขๅฟƒใŒใ‚ใ‚‹ๆ–นใฏใ€ๅŒป็™‚ๆฉŸ้–ขใงใฎๆœ€ๆ–ฐใฎๆฒป็™‚ๆณ•ใซใคใ„ใฆ็›ธ่ซ‡ใ—ใฆใฟใฆใใ ใ•ใ„ใ€‚
  • ๅฅๅบท็š„ใช้ฃŸ็”Ÿๆดปใ‚’ๅฟƒใŒใ‘ใ€ๅ…็–ซๅŠ›ใ‚’้ซ˜ใ‚ใ‚‹ๆ „้คŠ็ด ใ‚’ๆ„่ญ˜็š„ใซๆ‘‚ๅ–ใ—ใพใ—ใ‚‡ใ†ใ€‚
  • ๅฎšๆœŸ็š„ใช้‹ๅ‹•ใฏๅ…็–ซๆฉŸ่ƒฝใ‚’ใ‚ตใƒใƒผใƒˆใ—ใพใ™ใฎใงใ€ๆ—ฅๅธธ็š„ใซไฝ“ใ‚’ๅ‹•ใ‹ใ™ใ“ใจใ‚’ใŠๅ‹งใ‚ใ—ใพใ™ใ€‚
  • ใ‚นใƒˆใƒฌใ‚น็ฎก็†ใ‚‚้‡่ฆใงใ™ใ€‚ใƒชใƒฉใ‚ฏใ‚ผใƒผใ‚ทใƒงใƒณใ‚„่ถฃๅ‘ณใฎๆ™‚้–“ใ‚’ๅคงๅˆ‡ใซใ—ใพใ—ใ‚‡ใ†ใ€‚

โš ๏ธ ้™็•Œ/่ชฒ้กŒ

ๆœฌ็ ”็ฉถใซใฏใ„ใใคใ‹ใฎ้™็•ŒใŒใ‚ใ‚Šใพใ™ใ€‚ใพใšใ€ใƒžใ‚ฆใ‚นใƒขใƒ‡ใƒซใงๅพ—ใ‚‰ใ‚ŒใŸ็ตๆžœใŒใƒ’ใƒˆใซใใฎใพใพ้ฉ็”จใงใใ‚‹ใ‹ใฏไธๆ˜Žใงใ™ใ€‚ใพใŸใ€APOE่„‚่ณช็ฒ’ๅญใฎๅฝนๅ‰ฒใ‚„ใใฎใƒกใ‚ซใƒ‹ใ‚บใƒ ใซใคใ„ใฆใฎ็†่งฃใฏใพใ ไธๅฎŒๅ…จใงใ‚ใ‚Šใ€ใ•ใ‚‰ใชใ‚‹็ ”็ฉถใŒๅฟ…่ฆใงใ™ใ€‚ๅŠ ใˆใฆใ€ๆฒป็™‚ๆณ•ใฎๅฎŸ็”จๅŒ–ใซใฏๅคšใใฎ่‡จๅบŠ่ฉฆ้จ“ใŒๅฟ…่ฆใงใ™ใ€‚

ใพใจใ‚

่…ซ็˜ๅ†…ใฎๅฃŠๆญป่„‚่ณชๆ”พๅ‡บใ‚’ๆจ™็š„ใจใ™ใ‚‹ใ“ใจใŒใ€่„ณ่…ซ็˜ใซใŠใ‘ใ‚‹ๅ…็–ซ็›ฃ่ฆ–ใจใŒใ‚“ๅ…็–ซ็™‚ๆณ•ใ‚’ๅ‘ไธŠใ•ใ›ใ‚‹ๅฏ่ƒฝๆ€งใŒใ‚ใ‚‹ใ“ใจใŒ็คบใ•ใ‚Œใพใ—ใŸใ€‚ไปŠๅพŒใฎ็ ”็ฉถใŒใ“ใฎๅˆ†้‡Žใซๆ–ฐใŸใชๆฒป็™‚ๆณ•ใ‚’ใ‚‚ใŸใ‚‰ใ™ใ“ใจใ‚’ๆœŸๅพ…ใ—ใฆใ„ใพใ™ใ€‚

ๅ‚่€ƒๆ–‡็Œฎ

ๅŽŸ้กŒ Targeting necrotic lipid release in tumors enhances immunosurveillance and cancer immunotherapy of glioblastoma.
ๆŽฒ่ผ‰่ชŒ(ๅนด) Cell Res (2025 Sep 3)
DOI doi: 10.1038/s41422-025-01155-y
PubMed URL https://pubmed.ncbi.nlm.nih.gov/40903538/
PMID 40903538

ๆ›ธ่ชŒๆƒ…ๅ ฑ

DOI 10.1038/s41422-025-01155-y
PMID 40903538
PubMed URL https://pubmed.ncbi.nlm.nih.gov/40903538/
็™บ่กŒๅนด 2025
่‘—่€…ๅ Ji Yapeng, Jiang Junyao, Hu Lei, Lin Peng, Zhou Mingshan, Hu Song, Wang Minkai, Ji Yuchen, Liu Xianzhi, Yan Dongming, Guo Yang, Sathe Adwait Amod, Evers Bret M, Xing Chao, Luo Xuelian, Xie Qi, Pei Weike, Zhang Zhenyu, Yu Hongtao
่‘—่€…ๆ‰€ๅฑž Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, Zhejiang, China. / School of Life Sciences, Westlake University, Hangzhou, Zhejiang, China. / New Cornerstone Science Laboratory, School of Life Sciences, Westlake University, Hangzhou, Zhejiang, China. / Department of Neurosurgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China. / Department of Neurosurgery, Henan Provincial People's Hospital, Zhengzhou, Henan, China. / Eugene McDermott Center for Human Growth and Development, University of Texas Southwestern Medical Center, Dallas, TX, USA. / Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX, USA. / Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX, USA. / Department of Neurosurgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China. fcczhangzy1@zzu.edu.cn. / Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, Zhejiang, China. yuhongtao@westlake.edu.cn.
้›‘่ชŒๅ Cell research

่ซ–ๆ–‡่ฉ•ไพก

่ฉ•ไพกใƒ‡ใƒผใ‚ฟใชใ—

้–ข้€ฃ่ซ–ๆ–‡

2026.01.11 ๅ…็–ซ็™‚ๆณ•

ใŒใ‚“ๆฒป็™‚ๅˆๆœŸ่ฉฆ้จ“ใฎๆ‹กๅคงใ‚ณใƒ›ใƒผใƒˆใฎไฝ“็ณป็š„ใƒฌใƒ“ใƒฅใƒผ

Expansion cohorts in phase 1 oncology trials: a systematic review of their design, implementation and outcomes.

ๆ›ธ่ชŒๆƒ…ๅ ฑ

DOI 10.1038/s41416-025-03334-5
PMID 41520059
PubMed URL https://pubmed.ncbi.nlm.nih.gov/41520059/
็™บ่กŒๅนด 2026
่‘—่€…ๅ Herrero Colomina Julio, Hu Xinjie, Dinizulu Habana, Yan Ruiyang, Poles Ereny, Dawson Rhona, Yap Christina, Carter Louise
้›‘่ชŒๅ British journal of cancer
2025.09.18 ๅ…็–ซ็™‚ๆณ•

RNAไฟฎ้ฃพใ‚ทใ‚นใƒ†ใƒ ใ‚’ๆฒป็™‚ใฎใ‚ฟใƒผใ‚ฒใƒƒใƒˆใจใ—ใฆ

RNA modification systems as therapeutic targets.

ๆ›ธ่ชŒๆƒ…ๅ ฑ

DOI 10.1038/s41573-025-01280-8
PMID 40962853
PubMed URL https://pubmed.ncbi.nlm.nih.gov/40962853/
็™บ่กŒๅนด 2026
่‘—่€…ๅ Zhang Linda, Wei Jiangbo, Zou Zhongyu, He Chuan
้›‘่ชŒๅ Nature reviews. Drug discovery
2025.09.10 ๅ…็–ซ็™‚ๆณ•

ไบบ้–“B็ดฐ่ƒžใจCD40L็™บ็พใฎๅŸบ่ณช็ดฐ่ƒžใฎ3Dๅ…ฑๅŸน้คŠใ‚’ๅฏ่ƒฝใซใ™ใ‚‹่ถ…ไฝŽไป˜็€่กจ้ขใซใ‚ˆใ‚‹ไฝ“ๅค–ใงใฎไบŒๆฌกใƒชใƒณใƒ‘ๅ™จๅฎ˜ใฎๆจกๅ€ฃ

Ultra-low attachment surface enabling 3D co-culture of human B cells with CD40L-expressing stromal cells for mimicry of secondary lymphoid organs.

ๆ›ธ่ชŒๆƒ…ๅ ฑ

DOI 10.1039/d5bm01039j
PMID 40923296
PubMed URL https://pubmed.ncbi.nlm.nih.gov/40923296/
็™บ่กŒๅนด 2025
่‘—่€…ๅ Kumar Ananta, Park Kyoung Hwan, Huh Kang Moo, Roh Kyung-Ho
้›‘่ชŒๅ Biomaterials science
  • ใŒใ‚“ใƒป่…ซ็˜ๅญฆ
  • ใƒกใƒณใ‚ฟใƒซใƒ˜ใƒซใ‚น
  • ๅ…็–ซ็™‚ๆณ•
  • ๅŒป็™‚AI
  • ๅ‘ผๅธๅ™จ็–พๆ‚ฃ
  • ๅนน็ดฐ่ƒžใƒปๅ†็”ŸๅŒป็™‚
  • ๅพช็’ฐๅ™จใƒปๅฟƒ่‡“็—…
  • ๆ„ŸๆŸ“็—‡ๅ…จ่ˆฌ
  • ๆบๅธฏ้›ป่ฉฑ้–ข้€ฃ๏ผˆใ‚นใƒžใƒผใƒˆใƒ•ใ‚ฉใƒณ๏ผ‰
  • ๆ–ฐๅž‹ใ‚ณใƒญใƒŠใ‚ฆใ‚คใƒซใ‚นๆ„ŸๆŸ“็—‡
  • ๆ „้คŠใƒป้ฃŸไบ‹
  • ็ก็œ ็ ”็ฉถ
  • ็ณ–ๅฐฟ็—…
  • ่‚ฅๆบ€ใƒปไปฃ่ฌ็•ฐๅธธ
  • ่„ณๅ’ไธญใƒป่ช็Ÿฅ็—‡ใƒป็ฅž็ตŒ็–พๆ‚ฃ
  • ่…ธๅ†…็ดฐ่Œ
  • ้‹ๅ‹•ใƒปใ‚นใƒใƒผใƒ„ๅŒปๅญฆ
  • ้บไผๅญใƒปใ‚ฒใƒŽใƒ ็ ”็ฉถ
  • ้ซ˜้ฝขๅŒปๅญฆ

ยฉ ใ‚ใ‹ใ‚‹ๅŒปๅญฆ่ซ–ๆ–‡ All Rights Reserved.

TOPใธๆˆปใ‚‹